Why Traders Are Watching: Emerson Radio (NYSEMKT:MSN), Procter & Gamble (NYSE:PG), Goodyear Tire & Rubber (NASDAQ:GT), Ocera (NASDAQ:OCRX), Xerium Technologies (NYSE:XRM)


Emerson Radio Corp. (NYSE MKT: MSN), reported financial results for its third quarter and nine month period ended December 31, 2014. Net product sales for the third quarter of fiscal 2015 were $19.6 million, as compared to $18.4 million for the third quarter of fiscal 2014, an increase of $1.2 million, or 6.3%. On Wednesday shares of Emerson Radio Corp. (NYSEMKT:MSN) closed at $1.35. Company’s sales growth for last 5 years was -17.30.

On 10 February, The Procter & Gamble Company (NYSE: PG) announced the appointment of Francis S. Blake, 65, former Chairman of the Board and Chief Executive Officer of The Home Depot, Inc. to its board of directors. The appointment is effective immediately. The Procter & Gamble Company (NYSE:PG) in last trading activity increased 0.90% to close at $86.26. Company weekly performance is 1.02% while its quarterly performance stands at -1.41%. The Procter & Gamble Company (NYSE:PG) is -7.47% away from its 52 week high.

The Goodyear Tire & Rubber Company (NASDAQ:GT) reported better-than-expected fourth-quarter earnings. The Akron, Ohio-based company posted quarterly net income of $2.13 billion, or $7.68 per share up from $228 million or $0.84 per share, in the year-ago period. Excluding certain significant items, Goodyear earned $0.59 per share. On last trading day The Goodyear Tire & Rubber Company (NASDAQ:GT) moved up 2.89% to close at $27.39. Its volatility for the week is 2.58% while volatility for the month is 2.53%. GT’s sales growth for past 5 years was 0.10% and its EPS growth for past 5 years was 54.40%. The Goodyear Tire & Rubber Company (NASDAQ:GT) monthly performance is 10.58%.

Ocera Therapeutics, Inc. (NASDAQ:OCRX) announced preliminary topline results from a Phase 2a investigator-sponsored study evaluating the company’s drug candidate OCR-002 (ornithine phenylacetate) versus placebo in patients with upper gastrointestinal bleeding (UGIB) associated with liver cirrhosis. Ocera Therapeutics, Inc. (NASDAQ:OCRX) has 26.89% insider ownership while its institutional ownership stands at 53.60%. In last trading activity company’s stock closed at $6.19.

Xerium Technologies, Inc. (NYSE:XRM), announced that it plans to release its financial results for the fourth quarter and full year of 2014 after the close of regular market trading on Tuesday, March 3, 2015.On last trading day Xerium Technologies Inc. (NYSE:XRM) fell -0.83% to close at $15.52. Its volatility for the week is 1.35% while volatility for the month is 2.73%. XRM’s sales growth for past 5 years was -3.00% and its EPS growth for past 5 years was -53.10%. Xerium Technologies Inc. (NYSE:XRM) monthly performance is -2.39%.


Leave a Reply

Your email address will not be published. Required fields are marked *